Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

G20 health summit looks to boost vaccine access, drugmakers offer cut-price shots

G20 health summit looks to boost vaccine access, drugmakers offer cut-price shots

CRISPIAN BALMER and FRANCESCO GUARASCIO LEADERS of the world's largest economies kicked off a global health summit on Friday, where drugmakers were expected to promise cut-price supplies of vaccines for poorer nations to help end the COVID-19 pandemic. The Group of 20 nations looked set to call for voluntary licensing and technology transfers to enable a rapid increase in vaccine production, but will sidestep a push from the United States and other nations to waive valuable patents for shots. The European Union will also promise to set up vaccination manufacturing hubs in Africa, which faces a dearth of doses. The…
Read More
EXCLUSIVE – G20 snubs COVID patent waiver, waters down pledge on WHO’s funding -draft

EXCLUSIVE – G20 snubs COVID patent waiver, waters down pledge on WHO’s funding -draft

FRANCESCO GUARASCIO LEADERS of the world's largest economies back "voluntary licensing" of COVID-19 vaccine patents, the draft conclusions of a summit show, watering down a U.S. push for waivers and earlier commitments to supply more funds to the World Health Organization. The draft document, seen by Reuters, lists commitments of G20 nations and other countries and is to be adopted on Friday at a Global Health Summit in Rome, one of this year's major events to coordinate global actions against the pandemic. The draft, which is still subject to changes, is the result of a compromise among experts from G20…
Read More